The interaction between cancer cells and CAFs through paracrine signaling pathways contributes to treatment resistance, particularly resistance to EGFR TKIs, by activating the IGF-1R pathway and downstream EMT and stemness signaling [9]. Here, EGFR is linked to cancer.